Cognitive Change Following MPTP Exposure
Neurol 40:261-264, Stern,Y.,et al, 1990
Capsular Hypesthetic Ataxic Hemiparesis
Stroke 21:24-33, Helgason,C.M.&Wilbur,A.C., 1990
Rapid Development of Myelopathy after HTLV-1 Infection Acquired by Transfusion During Cardiac Transplantation
NEJM 322:383-387, Gout,O.,et al, 1990
Clinicopath Conf
Familial Visceral Myopathy (Oculogastrointestinal Muscular Dystrophy) , Case 12-1990, NEJM 322:829-8, 1, 19, 1990
Clinicopath Conf
Sarcoidosis of CNS and Mediastinal Lymph Nodes, Case Record 6-1990, NEJM 322:388-397990., , 1990
Mortality Associated with Early and Late Levodopa Therapy Initiation in Parkinson's Disease
Neurol 40:265-269, Scigliano,G.,et al, 1990
Dopa-Responsive Dystonia:The Spectrum of Clinical Manifestations in a Large North American Family
Neurol 40:66-69, Nygaard,T.G.,et al, 1990
Subcutaneous Apomorphine in the Treatment of Parkinson's Disease
JNNP 53:96-101, Frankel,J.P.,et al, 1990
A Large Kindred with Autosomal Dominant Parkinson's Disease
Ann Neurol 27:276-282, Golbe,L.I.,et al, 1990
The Changing Patterns of Death Rates in Parkinsonism
Neurol 40:42-49, Kurtzke,J.F.&Murphy,F.M., 1990
Miller Fisher Syndrome Associated with Q Fever
JNNP 53:615-616, Diaz Ortuno,A.,et al, 1990
Neurological Deterioration in Young Adults with Phenylketonuria
Lancet 336:602-605, Thompson,A.J.,et al, 1990
Acute Triphenyltin Intoxication:A Case Report
JNNP 53:356-357, Wu,RM.,et al, 1990
Sustained Enteral Administration of Levodopa Increases and Interrupted Infusion Decreases Levodopa Dose Requirements
Neurol 40:995-997, Cedarbaum,J.M.,et al, 1990
Apomorphine Test to Predict Dopaminergic Responsiveness in Parkinsonian Syndromes
Lancet 336:32-34, Hughes,A.J.,et al, 1990
Two Decades of Increasing Mortality from Parkinson's Disease Among the US Elderly
Arch Neurol 47:731-734, Lilienfeld,D.E.,et al, 1990
Environmental Risk Factors in Parkinson's Disease
Neurol 40:1218-1221, Koller,W.,et al, 1990
Pyramid Sale in the Bucket Shop:DATATOP Bottoms Out
Neurol 40:1337-1339, Landau,W.M., 1990
Parkinsonism Due to a Basal Ganglia Lacunar State:Clinicopathologic Correlation
Neurol 40:897-900, Murrow,R.W.,et al, 1990
Cell Implantation in Parkinson's Disease
BMJ 301:301-302, Williams,A., 1990
Transplantation of Human Fetal Dopamine Cells for Parkinson's Disease
Arch Neurol 47:505-512, Freed,C.R.,et al, 1990
Parkinson's Disease, Review Article
Lancet 335:948-952, Marsden,C.D., 1990
Magnetic Resonance Imaging in Parkinson's Disease
Arch Neurol 47:735-737, Huber,S.J.,et al, 1990
Clozapine in the Treatment of Parkinsonian Patients with Dopaminomimetic Psychosis
Neurol 40:832-834, Wolters,E.Ch.,et al, 1990
Decreased Efficacy of Levodopa with Carbidopa in Parkinsonian Patients after Adrenal-to-Caudate Implants
Neurol 40:845-846, Tsui,J.K.C.,et al, 1990
Parkinson's Disease and Driving Ability
JNNP 53:580-582, Madeley,P.,et al, 1990
Hereditary Motor and Sensory Neuropathies and Hereditary Spastic Paraplegia:A Magnetic Stimulation Study
Ann Neurol 28:43-49, Claus,D.,et al, 1990
Chronic Injuries of the Spinal Cord:Assessment with MR Imaging
Radiology 175:849-854, Yamashita,Y.,et al, 1990
A Comparison of Effects of Controlled-Release Levodopa (Madopar CR) with Levodopa in Late Parkinson's Disease
JNNP 53:220-223, MacMahon,D.G.,et al, 1990
Idiopathic Cerebellar Ataxia of Late Onset:Natural History and MRI Morphology
JNNP 53:297-305, Klockgether,T.,et al, 1990
Neurologic Manifestations of Giant Cell Arteritis
Am J Med 89:67-72, Reich,K.A.,et al, 1990
PET Study in Progressive Supranuclear Palsy, Hypometabolic Pattern
Arch Neurol 47:747-752, Blin,J.,et al, 1990
Excessive Muscular Fatigue in Patients with Spastic Paraparesis
Neurol 40:1271-1274, Miller,R.G.,et al, 1990
Retroviruses and Multiple Sclerosis. I. Analysis of Seroreactivity by Western Blot and Radioimmune Assay
Neurol 40:1251-1253, Weinshenker,B.G.,et al, 1990
Retroviruses & Multiple Sclerosis. II. Failure of Gene Amplification Techniques to Detect Viral Sequences
Neurol 40:1254-1258, Dekaban,G.A.&Rice,G.P.A., 1990
Botulinum Toxin Treatment of Cranial-Cervical Dystonia, Spasmodic Dystonia, Focal Dystonias & Hemifacial Spasm
JNNP 53:633-639, Jankovic,J.,et al, 1990
Assessment:The Clinical Usefulness of Botulinum Toxin-A in Treating Neurologic Disorders
Subcommittee Report, Neurol 40:1332-13361990., , 1990
Cortical-Basal Ganglionic Degeneration
Neurol 40:1203-1212, Riley,D.E.,et al, 1990
Striatonigral Degeneration:Clinical, MRI, & Pathologic Correlation
Neurol 40:710-711, O'Brien,C.,et al, 1990
Geriatrics:Gait Disorders in the Elderly
NEJM 322:1441-1446, Sudarsky,L., 1990
A Patient with Progressive Myelopathy and Antibodies to HTLV-I & HIV Type I in Serum and Cerebrospinal Fluid
Arch Neurol 47:477-479, Aboulafia,D.M.,et al, 1990
Demyelinating Changes in Sural Nerve Biopsy of Patients with HTLV-I-Associated Myelopathy
Neurol 40:1263-1266, Sugimura,K.,et al, 1990
HTLV-I-Associated Myelopathy
NEJM 323:552, Engel,W.K.,et al, 1990
Transvrse Myelitis and Spastic Paraparesis in a Patient with HIV Infection
NEJM 322:1322, Dodson,D., 1990
Nationwide Survey of HTLV-I-Associated Myelopathy in Japan:Ass with Blood Transufsion
Ann Neurol 28:50-56, Osame,M.,et al, 1990
Familial Spastic Paraparesis Syndrome Associated with HTLV-I Infection
NEJM 323:732-737, Salazar-Grueso,E.F.,et al, 1990
Multiple Sclerosis or HTLV-I Myelitis
Neurol 40:1020-1022, Poser,C.M.,et al, 1990
'Rubral'Gait Ataxia
Neurol 40:1004-1005, Felice,K.J.,et al, 1990
Migraine Assoc with Focal Cerebral Edema, CSF Pleocytosis, & Prog Cerebellar Ataxia:MRI Documentation
Neurol 40:1284-1287, Goldstein,J.M.,et al, 1990
Stereotaxic Thalamotomy-Experiences from the Levodopa Era
JNNP 53:427-430, Wester,K.&Hauglie-Hanssen,E., 1990